The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models
Open accessAbstract
// Chrysi Xintaropoulou 1 , Carol Ward 1 , Alan Wise 2 , Hugh Marston 2, 4 , Arran Turnbull 3 , Simon P. Langdon 1 1 Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK 2 IOMET Pharma, Nine, Edinburgh BioQuarter, Edinburgh, EH16 4UX, UK 3 Breakthrough Breast Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK 4 Current Address: Eli Lilly Research and Development, Windlesham, Surrey, GU20 6PH, UK Correspondence to: Simon P. Langdon, e-mail: Simon.Langdon@ed.ac.uk Keywords: glycolysis, inhibitors, ovarian cancer, breast cancer Received: May 12, 2015 Accepted: June 29, 2015 Published: July 16, 2015 ABSTRACT Many cancer cells rely on aerobic glycolysis for energy production and targeting of this pathway is a potential strategy to inhibit cancer cell growth. In this study, inhibition of five glycolysis pathway molecules (GLUT1, HKII, PFKFB3, PDHK1 and LDH) using 9 inhibitors (Phloretin, Quercetin, STF31, WZB117, 3PO, 3-bromopyruvate, Dichloroacetate, Oxamic acid, NHI-1) was investigated in panels of breast and ovarian cancer cell line models. All compounds tested blocked glycolysis as indicated by increased extracellular glucose and decreased lactate production and also increased apoptosis. Sensitivity to several inhibitors correlated with the proliferation rate of the cell lines. Seven compounds had IC 50 values that were associated with each other consistent with a shared mechanism of action. A synergistic interaction was revealed between STF31 and Oxamic acid when combined with the antidiabetic drug metformin. Sensitivity to glycolysis inhibition was also examined under a range of O 2 levels (21% O 2 , 7% O 2 , 2% O 2 and 0.5% O 2 ) and greater resistance to the inhibitors was found at low oxygen conditions (7% O 2 , 2% O 2 and 0.5% O 2 ) relative to 21% O 2 conditions. These results indicate growth of breast and ovarian cancer cell lines is dependent on all the targets examined in the glycolytic pathway with increased sensitivity to the inhibitors under normoxic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“In contrast, cancer cells frequently utilise glycolysis even in the presence of sufficient amounts of oxygen [1, 2].”
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 2×
“Many of the glycolytic enzymes, including all the targets selected here (GLUT1, Hexokinase II, PFKFB3, PDHK1 and LDHA), are known to be HIF1-inducible [32].”
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Zordoky, B. N. M., Bark, D., Soltys, C. L., Sung, M. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.023 · Cited by 98
Martin, H.-J., Kornmann, F., & Fuhrmann, G. F. (2003) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2003.06.001 · Cited by 80
Cited by
The anti-cancer effect of quercetin: molecular implications in cancer metabolism
Reyes-Farias, M., & Carrasco-Pozo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133177 · Cited by 689
“Quercetin (0–200 μM, 24 h incubation [61] and 0–300 μM, 5 days incubation [58]) inhibited the cell viability of colon cancer cell lines HCT-15 and RKO [61] and inhibited the proliferation of the breast cancer cell lines MCF-7, MDA-MB-231, HBL100 and BT549, and the ovarian cancer cell lines, OVCAR5, TOV112D, OVCAR3 and…”
InfluentialGao, F., Tang, Y., Liu, W., Zou, M., Huang, C., Liu, C., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201904639 · Cited by 357
Glucose transporter 1 critically controls microglial activation through facilitating glycolysis
Wang, L., Pavlou, S., Du, X., Bhuckory, M., Xu, H., & Chen, M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0305-9 · Cited by 335
Jia, L., Huang, S., Yin, X., Zan, Y., Guo, Y., & Han, L. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.027 · Cited by 304
The Warburg Effect 97 Years after Its Discovery
Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F., & Feo, F. (2020) · Cancers · doi:10.3390/cancers12102819 · Cited by 300
Metadata
- Authors
- Xintaropoulou, C., Ward, C., Wise, A., Marston, H., Turnbull, A., & Langdon, S. P.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-07-16
- Volume
- 6
- Issue
- 28
- Pages
- 25677-25695
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1941490733
- Cited by
- 159
- References
- 6
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.